236 related articles for article (PubMed ID: 34041673)
1. The role of long non-coding RNA BCAR4 in human cancers.
Yi Q; Liu Z; Zhang K; Liu X; Wang L; Geng B; Xia Y
Hum Cell; 2021 Sep; 34(5):1301-1309. PubMed ID: 34041673
[TBL] [Abstract][Full Text] [Related]
2. Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells.
Zou R; Chen X; Jin X; Li S; Ou R; Xue J; Yan X; Chen L; Hu Y; Zhu H
Surg Oncol; 2018 Jun; 27(2):306-313. PubMed ID: 29937186
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway.
Yan S; Xu J; Liu B; Ma L; Feng H; Tan H; Fang C
Bioengineered; 2021 Dec; 12(1):682-696. PubMed ID: 33602031
[TBL] [Abstract][Full Text] [Related]
4. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition.
Li N; Gao WJ; Liu NS
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2075-2086. PubMed ID: 28537678
[TBL] [Abstract][Full Text] [Related]
5. lncRNA BCAR4 Increases Viability, Invasion, and Migration of Non-Small Cell Lung Cancer Cells by Targeting Glioma-Associated Oncogene 2 (
Yang H; Yan L; Sun K; Sun X; Zhang X; Cai K; Song T
Oncol Res; 2019 Feb; 27(3):359-369. PubMed ID: 29615150
[TBL] [Abstract][Full Text] [Related]
6. The Functional Role of Oncogenic LncRNA BCAR4 for Cancer Outcome.
Wang B; Xu W; Cai Y; Liu K; Wu J; Guo C; Yuan C
Curr Pharm Des; 2021; 27(39):4107-4113. PubMed ID: 34086548
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Gong J; Zhang H; He L; Wang L; Wang J
Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
[TBL] [Abstract][Full Text] [Related]
8. LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer.
Wu T; Li X; Yan G; Tan Z; Zhao D; Liu S; Wang H; Xiang Y; Chen W; Lu H; Liao X; Li Y; Lu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):14. PubMed ID: 36627684
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
10. LncRNA BCAR4 promotes liver cancer progression by upregulating ANAPC11 expression through sponging miR‑1261.
Zhang Y; Zhou H
Int J Mol Med; 2020 Jul; 46(1):159-166. PubMed ID: 32319544
[TBL] [Abstract][Full Text] [Related]
11. Role of long non-coding RNA TP73-AS1 in cancer.
Chen C; Shu L; Zou W
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652459
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells.
Eroğlu Güneş C; Güçlü E; Vural H; Kurar E
Gene; 2021 Dec; 805():145904. PubMed ID: 34418470
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA Breast cancer antiestrogen resistance 4 is associated with cancer progression and its significant prognostic value.
Zhao W; Wang Z; Fang X; Li N; Fang J
J Cell Physiol; 2019 Aug; 234(8):12956-12963. PubMed ID: 30537165
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA BCAR4 accelerates cell proliferation and suppresses cell apoptosis in gastric cancer via regulating MAPK/ERK signaling.
Zhou GR; Huang DP; Sun ZF; Zhang XF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3657-3664. PubMed ID: 32329841
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
Chen F; Mo J; Zhang L
Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
